{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.58","meta":{"versionId":"3","lastUpdated":"2023-04-03T16:12:03.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.58","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.58"}],"version":"20150714","name":"TrastuzumabAdministration","title":"Trastuzumab Administration","status":"active","experimental":false,"date":"2015-07-14T01:00:00-04:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"327397006","display":"Trastuzumab (product)"},{"code":"327399009","display":"Trastuzumab 150mg powder for infusion solution vial (product)"},{"code":"375356000","display":"Trastuzumab 440mg powder for injection solution vial (product)"},{"code":"387003001","display":"Trastuzumab (substance)"},{"code":"702836004","display":"Trastuzumab emtansine (substance)"}]}]},"expansion":{"identifier":"urn:uuid:8826fa02-6412-46c5-b566-efcac07d41ec","timestamp":"2023-12-10T21:42:58-05:00","total":5,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"327397006","display":"Product containing trastuzumab (medicinal product)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"327399009","display":"Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection (clinical drug)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"375356000","display":"Product containing precisely trastuzumab 440 milligram/1 vial powder for conventional release solution for injection (clinical drug)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"387003001","display":"Trastuzumab (substance)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"702836004","display":"Trastuzumab emtansine (substance)"}]}}